Quote
—
—
No scored catalysts in the window yet.
Market cap
—
P/E
—
EPS
—
Beta
—
52W range
—
Day range
—
Open
—
Prev close
—
Volume
—
Avg volume
—
Dividend
—
IPO
—
https://www.marketwatch.com/story/one-of-the-markets-most-durable-growth-sectors-has-been-passed-over-for-ai-says-jpmorgan-b726011c · 7/30/2026+0.80
https://247wallst.com/investing/2026/07/27/forget-social-security-5-sleep-at-night-dividend-stocks-retirees-are-using-to-replace-a-paycheck/ · 7/27/2026+0.70
https://www.fool.com/investing/2026/07/26/better-dividend-king-to-buy-now-abbvie-or-j-and-j/ · 7/26/2026+0.60
https://247wallst.com/investing/2026/07/23/hdv-delivers-3-1-yield-while-beating-spy-year-to-date-by-9-points/ · 7/23/2026+0.40
https://247wallst.com/investing/2026/07/19/3-biggest-pharma-giants-buy-sell-or-hold/ · 7/19/2026-0.60
https://www.proactiveinvestors.co.uk/companies/news/1095617 · 7/17/2026+0.20
https://www.prnewswire.com/news-releases/le-rapport-annuel-de-piramal-pharma-pour-lexercice-2026-souligne-lenvergure-mondiale-de-la-societe-sa-croissance-axee-sur-linnovation-et-ses-avancees-majeures-en-matiere-de-developpement-durable-302820309.html · 7/8/2026+0.30
https://www.prnewswire.com/news-releases/abbvie-announces-tepkinly-epcoritamab-in-combination-with-lenalidomide-and-rituximab-is-approved-by-the-european-commission-for-the-treatment-of-relapsed-or-refractory-follicular-lymphoma-302818589.html · 7/6/2026+1.00
https://247wallst.com/investing/etf/2026/07/05/six-dividend-aristocrats-keeping-schds-income-stream-bulletproof-this-year/ · 7/5/2026+0.70
https://www.wsj.com/health/pharma/genmab-shares-climb-after-lymphoma-therapy-hits-goal-in-trial-64ebf887 · 6/30/2026+0.80
https://www.marketwatch.com/story/healthcare-stocks-have-become-a-haven-for-investors-ditching-tech-81c544d0 · 6/26/2026+1.00
https://www.fool.com/investing/2026/06/22/why-abbvie-stock-is-up-today/ · 6/23/2026+0.60
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
